The object
Caroline Moreau co-developed a Parkinson's treatment system that uses an implanted abdominal pump and fine catheter to continuously deliver anaerobic dopamine to the brain. The approach addresses advanced Parkinson's symptoms by stabilizing dopamine delivery; Moreau co-authored its 2025 phase 1/2 clinical-trial report.
01
What Caroline did
Co-developed an implanted dosing-pump and catheter system that continuously delivers anaerobic dopamine to the brain.
02
Why it matters
The system pairs an implantable pump with direct central-nervous-system delivery to address a limitation of conventional dopamine therapy.
03
Living-status check
Moreau co-authored the Nature Medicine trial published January 7, 2025 and was an EPO inventor-award finalist in 2024.